EP0461886A1 - Method for preventing coagulation of powder - Google Patents

Method for preventing coagulation of powder Download PDF

Info

Publication number
EP0461886A1
EP0461886A1 EP91305321A EP91305321A EP0461886A1 EP 0461886 A1 EP0461886 A1 EP 0461886A1 EP 91305321 A EP91305321 A EP 91305321A EP 91305321 A EP91305321 A EP 91305321A EP 0461886 A1 EP0461886 A1 EP 0461886A1
Authority
EP
European Patent Office
Prior art keywords
powder
water
coagulation
cellulose ester
soluble cellulose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP91305321A
Other languages
German (de)
English (en)
French (fr)
Inventor
Tadao Onaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tosoh Corp
Original Assignee
Tosoh Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tosoh Corp filed Critical Tosoh Corp
Publication of EP0461886A1 publication Critical patent/EP0461886A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/30Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic using agents to prevent the granules sticking together; Rendering particulate materials free flowing in general, e.g. making them hydrophobic

Definitions

  • the present invention relates to a method for preventing coagulation of powder which is likely to be coagulated. More particularly, it relates to a method for preventing coagulation of powder by using a water-soluble cellulose ester as an anticoagulant.
  • a powder of an amine such as piperazine or triethylenediamine (hereinafter referred to simply as TEDA) is a compound which usually has coherence and adherence and thus is likely to be coagulated.
  • TEDA triethylenediamine
  • a highly hydroscopic powder or a highly sublimable powder in general usually readily undergoes coagulation due to an inclusion of a small amount of moisture or due to an increase of the temperature. Therefore, such a coagulable powder is required to be handled with due care, and once such a powder has coagulated, the handling tends to be extremely difficult.
  • Such a powder has extremely high coagulability, and it is usually difficult to prevent the coagulation by enlarging the particle size.
  • As a method for preventing coagulation of such a highly coagulable powder it is usually believed to be effective to incorporate a suitable anticoagulant.
  • an anticoagulant which is capable of effectively accomplishing the object in an amount as small as possible and which does not impart an odor or a color to the powder by the addition. Further, it is desired to select an anticoagulant which presents no adverse effects to the physical properties of the powder in connection with the purpose of the powder and which is inexpensive.
  • conventional anticoagulants silica powder (Japanese Unexamined Patent Publication No. 203039/1982) and polyethylene glycols (Japanese Examined Patent Publication No. 46758/1988) are known. However, the silica powder is effective only to temporarily avoid the contact of crystals to one another and its anti-coagulating action is very weak.
  • liquid anticoagulants such as polyethylene glycols may simply be mixed with TEDA powder.
  • the TEDA powder tends to be wet, and in a long range storage, the liquid tends to flow to the bottom of the container and tends to be non-uniform in the container, whereby the anti-coagulating action tends to be low.
  • the anticoagulant is required to be added at a relatively high concentration, whereby the purity of TEDA will be low.
  • Japanese Examined Patent Publications No. 62241/1988 and No. 3142/1989 disclose that by an addition of a TEDA polymer (ethylene-piperazine copolymer) as an additive during a precipitation step, it is possible to simplify the process of the addition so that the process control can be easy, and the TEDA polymer exhibits a high level of anti-coagulating action, whereby adequate effects can be obtained by an addition of a very small amount of the polymer.
  • this TEDA polymer is insoluble in most organic solvents.
  • Powders usually have coherence and adherence in many cases. It is common to employ an operation such as granulation or classification to reduce such nature. However, in a case of a coagulable powder such as a highly sublimable powder of e.g. TEDA, sublimation and condensation are repeated due to a change of e.g. the external temperature, whereby a strong bridge will be formed between powder particles (crystals). Thus, TEDA tends to be coagulated entirely in the container and tends to be hardly disintegrated.
  • a coagulable powder such as a highly sublimable powder of e.g. TEDA
  • sublimation and condensation are repeated due to a change of e.g. the external temperature, whereby a strong bridge will be formed between powder particles (crystals).
  • TEDA tends to be coagulated entirely in the container and tends to be hardly disintegrated.
  • TEDA is usually synthesized or produced from e.g. N-aminoethylpiperazine or hydroxyethylpiperazine. By such a method, TEDA is obtainable as slightly yellow white crystals. As a by-product, an alkylpiperazine or the like is contained. This by-product has an anti-coagulating action to some extent. However, TEDA crystals of high purity have been desired in recent years, and consequently, TEDA crystals having a purity of at least 99.9% are now produced as a result of an improvement in the purification technique. Accordingly, the coagulability of TEDA has been thereby sharply increased, and there has been a problem from the viewpoint of the production process or the storage.
  • the present invention provides a method for preventing coagulation of coagulable powder, which comprises incorporating to the powder a water-soluble cellulose ester alone or in combination with other anticoagulant, to control the coagulability.
  • the coagulable powder means a highly hygroscopic and/or sublimable powder of e.g. piperazine, TEDA, ammonium sulfate, ammonium chloride or sodium chloride.
  • the main causes for coagulation of powder i.e. coagulation due to absorption of moisture and coagulation due to bridging of powder particles (crystals) by sublimation and condensation.
  • the former can be avoided by packaging. Otherwise it can be avoided by improving the quality control of the product.
  • the present invention presents a very effective coagulation-preventing method by incorporating an anticoagulant which prevents absorption of moisture and the sublimation and condensation action.
  • the mechanism for preventing coagulation in the present invention is considered to be as follows.
  • Water-soluble cellulose esters exhibit excellent solubility to various solvents and they are capable of forming transparent strong films from their solutions in water or in organic solvents.
  • a solution of such a water-soluble cellulose ester in water or in an organic solvent is mixed to the powder, followed by drying to form a film on the surface of the powder and thereby to microcapsulate the crystals, so that the contact of the crystal-forming component with outer atmosphere or the contact of crystals to one another is prevented, whereby the absorption of moisture and the sublimation and condensation, are suppressed.
  • coagulation of crystals to one another is suppressed, and coagulation-preventing effects can be obtained.
  • the water-soluble cellulose ester in the present invention may, for example, be a compound of the following formula (1): wherein n is an integer of at least 1, and R is H or a branched or linear C1-C10 alkyl group or ⁇ -CH2-CH(OH)CH3- O H, wherein m is an integer of at least 1.
  • methyl cellulose, ethyl cellulose, hydroxypropylmethyl cellulose or propyl cellulose may be mentioned.
  • particularly preferred is hydroxypropylmethyl cellulose and propyl cellulose.
  • a product having the hydroxyl group in the cellulose residue substituted by a methoxy group, a hydroxylpropoxy group or both of them, is commercially available as Metlose (manufactured by Shinetsu Chemical Co., Ltd.) or Nisso HPC (manufactured by Nippon Soda Co., Ltd.).
  • Such water-soluble cellulose esters are available with a wide range of molecular weights ranging from a low molecular weight of 10,000 to an average molecular weight exceeding 100,000, and the viscosities of their solutions are proportional to the average molecular weights. Selection of a particular water-soluble cellulose ester among such various water-soluble cellulose esters depends on the properties required. However, hydroxypropyl cellulose or hydroxypropylmethyl cellulose is preferred in a case where it is used as dissolved in a wide range of organic solvents when the powder is to be used. The average molecular weight of the water-soluble cellulose ester to be used may be at any level.
  • the water-soluble cellulose ester has an average molecular weight of from 10,000 to 100,000.
  • the method for adding a water-soluble cellulose ester to the powder there is no particular restriction as to the method for adding a water-soluble cellulose ester to the powder.
  • a method wherein after the preparation of powder, the powder and a solution of the water-soluble cellulose ester in water or in an organic solvent are thoroughly mixed by means of a mixing apparatus such as a ribbon blender or a V-type mixer.
  • a mixing apparatus such as a ribbon blender or a V-type mixer.
  • the process tends to be complex, and the cost is expected to be substantial.
  • a solution of the water-soluble cellulose ester in water or in an organic solvent is sprayed or otherwise added during the liquid removal step immediately after precipitation i.e.
  • Anticoagulants presently used are silica powders and polyethylene glycols.
  • the anticoagulating ability of such conventional additives is relatively low, and when the coagulable powder is TEDA, such conventional additives are required in an amount of about 1 part by weight per 100 parts by weight of TEDA.
  • the water-soluble cellulose ester is capable of forming a thin strong film, and a sufficient anti-coagulating action can be obtained when the water-soluble cellulose ester is contained in an amount of at least 0.001 part by weight relative to 100 parts by weight of TEDA. The larger the amount, the higher the anti-coagulating effects.
  • the purity of the powder decreases as the amount of the additive to the powder increases.
  • the amount of addition should preferably be as small as possible.
  • the amount of the water-soluble cellulose ester added to powder is preferably from 0.001 to 2 parts by weight, more preferably from 0.01 to 0.1 part by weight, per 100 parts by weight of the powder. This amount corresponds to from 1/10 to 1/100 of the amount of the conventional additives.
  • water-soluble cellulose esters are colorless and transparent and chemically very stable, and they are not substantially decomposed by acids or alkalis. Therefore, they do not adversely affect the physical properties of the powder, and they show excellent solubility to various solvents and thus have excellent properties as additives or coating agents.
  • the present invention provides an epoch-making coagulation-preventing technique in which a very small amount of a water-soluble cellulose ester is added to powder to coat it on the powder surface to impart excellent coagulation-preventing effects by suppressing moisture absorption and sublimation of the powder and preventing the contact of the powder particles to one another.
  • TEDA powder having a purity of at least 99.95% was used, and as an anticoagulant, methyl cellulose was used.
  • a TEDA cake 500 g was prepared on a Buechner funnel, and 200 ml of a 0.5% alcohol solution of the above anticoagulant was added thereto. The mixture was thoroughly mixed to contact the solution with TEDA crystals, followed by filtration to collect the TEDA crystals. The crystals were thoroughly dried under vacuum to obtain 350 g of a sample.
  • the quantitative analysis of the coated water-soluble cellulose ester was conducted in accordance with Japanese Pharmacopea. As a result, the coated amount was 0.05 g.
  • the measurement of the coagulation degree and the evaluation standards were as follows. Namely, the obtained sample was packed in a container having a size of 5 cm x 5 cm and a height of 2 cm, and a plastic plate of 5 cm x 5 cm was placed thereon. A weight of 300 g was placed thereon, and the container was stored in a desiccater having a humidity of not higher than 1%. During the storage, the pressure exerted to the crystals was 12 g/cm2. After the storage in the desiccater for one month, the weight and the container were removed, and a pressure was exerted to the center portion of the crystal block having the plastic plate located beneath, by a Kiya-type hardness meter, whereby the pressure at breakage was read. The values thus obtained were classified into the following three rankings, which were used as indices for evaluation of the coagulation degree. In the following Examples and Comparative Examples, the coagulation degree was evaluated in the same manner. The results are shown in Table 1.
  • Example 2 The operation was conducted in the same manner as in Example 1 except that as the anticoagulant, hydroxypropylmethyl cellulose was used instead of methyl cellulose.
  • the coated amount was 0.05 g/340 g.
  • Example 2 The operation was conducted in the same manner as in Example 1 except that as the anticoagulant, hydroxypropyl cellulose was used instead of methyl cellulose.
  • the coated amount was 0.06 g/350 g.
  • a TEDA methanol solution having a composition comprising 50 parts by weight of TEDA and 50 parts by weight of methanol was introduced into a flask having an internal capacity of 5,000 ml, and 0.15 g of TEDA polymer (ethylene-piperazine copolymer prepared by the synthesis disclosed in Japanese Unexamined Patent Publication No. 62241/1988), was added thereto.
  • the mixture was subjected to methanol removal by an evaporator, whereby 1,100 ml of methanol was distilled.
  • the residual liquid was left to stand still at a room temperature and then cooled to a liquid temperature of 20°C.
  • Precipitated TEDA crystals were collected by filtration under suction with a filter paper of No. 5C and then dried under vacuum to obtain 450 g of TEDA crystals.
  • the TEDA polymer contained in the TEDA crystals was 0.05 g. With respect to this sample, the coagulation degree was evaluated in the same manner as in Example 1.
  • Example 1 500 g of TEDA and 2 g of silica gel (manufactured by Nippon Silica Gel Kogyo K.K., bulk density: 40g/l, average particle size: 2 ⁇ m) were thoroughly mixed by a V-mixer, and the obtained mixture was used as a sample. Otherwise, the operation was conducted in the same manner as in Example 1. The results are as shown in Table 1, and a certain degree of coagulation was observed.
  • hydroxypropyl cellulose (Nisso HPC)
  • the coated amount and the coagulation-preventing effects were compared.
  • the operation was conducted in the same manner as in Example 1 except that instead of the alcohol solution of methyl cellulose, (1) 2%, (2) 1%, (3) 0.5%, (4) 0.1% or (5) 0.05% alcohol solution of hydroxypropyl cellulose, or (6) pure alcohol was used.
  • the amount of TEDA, the coated amount of hydroxypropyl cellulose and the coagulation preventing action are shown in Table 2. As is evident from Table 2, a certain degree of coagulation preventing action was observed even at a coated amount of 10 ppm, and excellent coagulation-preventing action was observed at a concentration of 100 ppm or higher. Further, no formation of turbidity or flowing substance was observed in solutions of various solvents such as alcohols, water and glycols.
  • aqueous ammonium sulfate solution having a composition comprising 40 parts by weight of ammonium sulfate and 60 parts by weight of water, was introduced, and 0.5 g of hydroxypropylmethyl cellulose was added thereto.
  • the mixture was heated by a mantle heater, and heating was stopped when 400 ml of water was distilled off.
  • the flask was immersed in a water bath and cooled until the liquid temperature became 20°C. Precipitated ammonium sulfate was collected by filtration under suction with a filter paper of No. 5C and washed with a small amount of pure water.
  • the product was dried under vacuum to obtain 240 g of ammonium sulfate.
  • hydroxypropylmethyl cellulose contained in the ammonium sulfate was 0.07 g.
  • This sample was subjected to evaluation of coagulation degree in the same manner as in Example 1. As a result, the coagulation degree was found to be A rank.
  • a composition of matter comprises a particulate material, the said particles carrying water soluble cellulose ester such as to reduce the tendency of the said particles to stick to each other.
  • the invention is particularly useful when applied to materials where particles of the material have a marked tendency to stick together i.e. to agglomerate; such process is also referred to herein as coagulation.
  • Materials which have a marked tendency for their particles to stick together include materials which are hygroscopic or which sublime.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Glanulating (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
EP91305321A 1990-06-12 1991-06-12 Method for preventing coagulation of powder Withdrawn EP0461886A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP151590/90 1990-06-12
JP2151590A JPH0683782B2 (ja) 1990-06-12 1990-06-12 粉体の固結防止方法

Publications (1)

Publication Number Publication Date
EP0461886A1 true EP0461886A1 (en) 1991-12-18

Family

ID=15521843

Family Applications (1)

Application Number Title Priority Date Filing Date
EP91305321A Withdrawn EP0461886A1 (en) 1990-06-12 1991-06-12 Method for preventing coagulation of powder

Country Status (4)

Country Link
EP (1) EP0461886A1 (pt)
JP (1) JPH0683782B2 (pt)
KR (1) KR920000371A (pt)
BR (1) BR9102437A (pt)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1787993A1 (en) * 2004-08-25 2007-05-23 Towa Chemical Industry Co., Ltd. Crystalline maltitol powder less prone to consolidation and method for production thereof
EP2204095A1 (de) 2008-12-23 2010-07-07 Basf Se Mischkristalle, Verfahren zu deren Herstellung und Verwendung in der Herstellung von Backwaren
CN114394973A (zh) * 2021-12-22 2022-04-26 西安近代化学研究所 一种棒状三乙烯二胺及其制备方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102594610B1 (ko) 2015-12-07 2023-10-26 스미토모 세이카 가부시키가이샤 고결 방지제를 포함하는 조성물

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1128192A (en) * 1964-12-04 1968-09-25 Organon Labor Ltd Process for rendering powders free flowing and the thus-obtained powders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5029510A (pt) * 1973-07-12 1975-03-25
JPS57106544A (en) * 1980-12-25 1982-07-02 Taiho Kogyo Co Ltd Water granulated slag solidification prevention

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1128192A (en) * 1964-12-04 1968-09-25 Organon Labor Ltd Process for rendering powders free flowing and the thus-obtained powders

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1787993A1 (en) * 2004-08-25 2007-05-23 Towa Chemical Industry Co., Ltd. Crystalline maltitol powder less prone to consolidation and method for production thereof
EP1787993A4 (en) * 2004-08-25 2012-05-30 Mitsubishi Shoji Foodtech Co Ltd CRYSTALLINE MALTITOL POWDER WITH LOW CONSOLIDATION AND MANUFACTURING METHOD THEREFOR
US10315974B2 (en) 2004-08-25 2019-06-11 Mitsubishi Shoji Foodtech Co., Ltd. Crystalline maltitol powder less prone to consolidation and method for production thereof
EP2204095A1 (de) 2008-12-23 2010-07-07 Basf Se Mischkristalle, Verfahren zu deren Herstellung und Verwendung in der Herstellung von Backwaren
US9894905B2 (en) 2008-12-23 2018-02-20 Basf Se Mixed crystals, method for the production thereof and use thereof in the production of baked goods
US10609931B2 (en) 2008-12-23 2020-04-07 Basf Se Mixed crystals, method for the production thereof and use thereof in the production of baked goods
CN114394973A (zh) * 2021-12-22 2022-04-26 西安近代化学研究所 一种棒状三乙烯二胺及其制备方法

Also Published As

Publication number Publication date
JPH0683782B2 (ja) 1994-10-26
KR920000371A (ko) 1992-01-29
JPH0445836A (ja) 1992-02-14
BR9102437A (pt) 1992-01-14

Similar Documents

Publication Publication Date Title
US5204024A (en) Method for preventing agglomeration of powder
KR100402038B1 (ko) 젤라틴제품을안정화시키기위한방법
CA1065312A (en) Viscosity reduction of cellulose derivatives
EP0025639A1 (en) Process for preparing porous cellulose spherical particles
US4063016A (en) Chitin complexes with alcohols and carbonyl compounds
EP0461886A1 (en) Method for preventing coagulation of powder
US5122300A (en) Method for preventing agglomeration of powder
EP0470715A2 (en) Method for preventing agglomeration of powder
US4228276A (en) Direct precipitation method for producing extrusion-grade cellulose acetate powder and resulting product
CA2044236A1 (en) Method for preventing coagulation of powder
KR20040063778A (ko) 분말상 비닐피롤리돈 중합체의 제조방법
US5980642A (en) Method for the removal of water from surfaces
EP0470774B1 (en) Method for preventing agglomeration of powder
US4001060A (en) Method for preparing an extrudable priming mixture containing modified karaya gum
CN114573836B (zh) 水凝胶及其生产方法
US4031024A (en) Process for improving the stability and shaping of anhydrous sodium metasilicate, and the compositions containing same, and the resulting products
US5026875A (en) Stability-improved trioxane composition
RU2041217C1 (ru) Способ предотвращения слипания порошка триэтилендиамина, сульфата аммония или хлорида аммония
US3989683A (en) Method of treating karaya gum
JPH04164077A (ja) 粉体の固結防止方法
US4839407A (en) Particulate polyacetal carboxylate and methods for preparation thereof
US3783165A (en) Soluble coffee antifoam and sludge suspending agents
CA2137580A1 (en) Polymer compositions and processes
SU1386877A1 (ru) Способ подготовки образцов блок-сополимеров дл электронно-микроскопического исследовани
JP3570782B2 (ja) 脂肪族エステル−アミド共重合樹脂多孔微粒子及びその製造方法

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

17P Request for examination filed

Effective date: 19920617

17Q First examination report despatched

Effective date: 19921208

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19931109